InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
QTG | Ann: Half Year Accounts | 22/02/19 | 0 | 170 | |||
|
|||||||
QTG | Ann: Change in substantial holding | 11/02/19 | 0 | 110 | |||
|
|||||||
QTG | Ann: Change in substantial holding | 05/02/19 | 0 | 94 | |||
|
|||||||
QTG | Ann: Change of Director's Interest Notice | 04/02/19 | 0 | 83 | |||
|
|||||||
QTG | Ann: Becoming a substantial holder | 04/02/19 | 0 | 118 | |||
|
|||||||
QTG | Ann: Change of Director's Interest Notice | 04/02/19 | 0 | 63 | |||
|
|||||||
QTG | Ann: Appendix 4C - quarterly | 30/01/19 | 0 | 120 | |||
|
|||||||
QTG | Ann: Renounceable Issue | 29/01/19 | 0 | 137 | |||
|
See All Discussions